Jodi Warman Chardon
Associate Scientist, Neuroscience
Ottawa Hospital Research Institute
Associate Scientist, Clinical Epidemiology
Ottawa Hospital Research Institute
Clinician Scientist, Neurology
The Ottawa Hospital
Associate Professor, Faculty of Medicine
University of Ottawa
Co-Director, Centre for Neuromuscular Disease, Faculty of Medicine
University of Ottawa
Research Interests
Dr. Warman-Chardon's primary research interest focuses on identifying the molecular basis and the clinical characterization of rare disease, utilizing imaging, novel genetic techniques to drive gene identification and the phenotypic expansion of many rare neuromuscular disorders. She and her colleagues have successfully identified several novel genes, and are continuing to assess evolving imaging, genomics and serum biomarkers as clinical tools to help patients living with neuromuscular disease.
Brief Biography
Dr Jodi Warman-Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease at the University of Ottawa. Dr. Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University, and PhD from McGill University. She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG). She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She was also co-director of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers. Dr. Warman-Chardon's research program and clinical practice focuses on the diagnosis and the clinical characterization of patients with rare or novel inherited neuromuscular disease by Magnetic Resonance Imaging (MRI), novel biomarker discovery and genomics diagnostics.
Selected Publications
Diseases, conditions and populations of interest
Research and clinical approaches
